Matches in Nanopublications for { ?s ?p "[Importantly, a related MCT1/2 inhibitor (AZD3965) is currently in phase I clinical trials in patients with advanced cancers: http://clinicaltrials.gov/show/NCT01791595.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP1239102.RA7-JSI-i_mADfPMEK93L3oOMc2_BUIvw8_02-tDVgGi8130_assertion description "[Importantly, a related MCT1/2 inhibitor (AZD3965) is currently in phase I clinical trials in patients with advanced cancers: http://clinicaltrials.gov/show/NCT01791595.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239102.RA7-JSI-i_mADfPMEK93L3oOMc2_BUIvw8_02-tDVgGi8130_provenance.
- NP1239103.RA3omhpUI0iyPRus4FrxkSutBMwT8VBJjXIcmLa-1wV1s130_assertion description "[Importantly, a related MCT1/2 inhibitor (AZD3965) is currently in phase I clinical trials in patients with advanced cancers: http://clinicaltrials.gov/show/NCT01791595.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239103.RA3omhpUI0iyPRus4FrxkSutBMwT8VBJjXIcmLa-1wV1s130_provenance.
- NP1239104.RAyi5GaPKT-xrw63bBJx7VwECi6RAxhlhem-vaFdasu5w130_assertion description "[Importantly, a related MCT1/2 inhibitor (AZD3965) is currently in phase I clinical trials in patients with advanced cancers: http://clinicaltrials.gov/show/NCT01791595.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239104.RAyi5GaPKT-xrw63bBJx7VwECi6RAxhlhem-vaFdasu5w130_provenance.